3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Breast Neoplasms
3
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Leukemia, Myeloid, Acute
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Advanced Malignant Solid Neoplasm
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
durvalumab
3
Taxes
3
futibatinib
2
fludarabine
2
Specimen Handling
2
Platinum
2
Paclitaxel
2
Nivolumab
2
Irinotecan
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
tocilizumab
1
tivozanib
1
tislelizumab
1
regorafenib
1
pevonedistat
1
pemigatinib
1
pembrolizumab
1
olutasidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.